Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.
about
Mechanisms Underlying HIV Associated Non-infectious Lung Disease.A method for assessing the global spread of HIV-1 infection based on air travel.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewMorphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.Patterns of survival with AIDS in the United States.Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like diseaseHIV-1 P24 antigenaemia does not predict time of survival in AIDS patientsThe natural history of human immunodeficiency virus infection: a five year study in a London cohort of homosexual menEmergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanismsPerspective on HIV infection and aging: emerging research on the horizon.Forecasting the personal medical care costs of AIDS from 1988 through 1991.The influence of age, smoking, antiretroviral therapy, and esophagitis on the local immunity of the esophagus in patients with AIDS.Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Updated forecasts of the costs of medical care for persons with AIDS, 1989-93HIV infection in the elderlySurrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.HIV-1 infection in a cohort of haemophilic patients.Treatment of HIV infection in the older patient.Causes of Death in HIV Patients and the Evolution of an AIDS Hospice: 1988-2008.Contraception and fertility plans in a cohort of HIV-positive women in care.Gender-specific considerations in the antiretroviral management of HIV-infected women.Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.Changing epidemiology of AIDS.Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study GroupHIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern ThailandHIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS.An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivoPharmacologic consideration for the use of antiretroviral agents in the elderly.AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease.Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly.HIV infection and intervention: the first decade.Gender specific differences in the immune response to infection.The response of general surgeons to HIV in England and Wales.Prevention of lung infections associated with human immunodeficiency virus infection.Claudin-2 downregulation by KSHV infection is involved in the regulation of endothelial barrier function.
P2860
Q30234727-CA1665A2-4234-4ECB-832A-85579D49379CQ30331912-81AA46EE-7B42-4E46-9C43-B4C421954570Q33566578-1DA70391-50A8-4E6A-87DA-2B38A2C40F8BQ33683180-B74D0C4C-99DC-456B-BA59-5F8039209A80Q33724696-C9F10415-BD2E-4316-8EB8-A3F0AE4180DAQ33781899-F0B7C859-A04C-4454-B9E5-A8B24D89C001Q33932589-7462E9AB-FC3C-427C-B41F-2D7437F6106EQ33932682-9E6F5BAA-D11B-48B4-8809-381E405FE70DQ33966519-6B0E5D41-7A82-461E-9ED1-D2BA7559B863Q34421694-A9885B24-CE8A-4E16-B243-E301A4E04DC1Q34444007-A48792E6-5783-4C53-B114-C15B6374C7A3Q34675815-259044E5-9EA4-4515-A8F6-89C58FDB2D5FQ34725060-100C9E48-55F3-46B5-A587-15C5CF97ADE3Q35000656-5BDC78B1-97E7-4A5A-A2AD-A55BE90159ECQ35054463-8502E8E6-113D-49C4-A8F0-3901C24CB0A7Q35086332-3E8B3AC4-7223-4A1E-B261-C22D2529EE22Q35178308-F3F7B6D0-3C3D-4BD5-BBE3-7CA38E9687ABQ35178519-9AD89174-C1AA-4269-B191-B3C46CFA7FCDQ35626762-A0CCF3D6-F7B2-403B-9693-9BD2A2CF213DQ35917538-AC595DC8-579D-4C85-AB98-C0E2D670ACE0Q35996517-D97A7643-FFBD-4482-83EC-619DDB1ABDA3Q36063050-46D8D373-A5CA-46A5-AD57-E3F4F0A9FB0AQ36140662-98C1A093-607E-412C-915D-F8998C7E5267Q36611448-B9CE017E-2D1F-434C-839E-C83E0B379FD8Q36653351-F7BED27A-2EBC-4670-BED7-DC0230175564Q36885046-9E059FC3-2D06-43BD-B4D2-8BDCAF942845Q36888435-B3165044-231A-42D4-8A58-E7FA9C39B556Q36904279-ED3F6790-8359-43ED-9364-A4BDA38819DDQ36956149-F5F657E6-019D-43DE-A8D9-AD2B7F192192Q37132597-BA1EA439-D750-42CB-ACD8-B3C9AD84EE6CQ37250125-D0C6BC49-DB6F-46B5-8188-6F13F40B51C8Q37252199-12A0EA54-251B-4E27-ACE9-B31452AC70C1Q37277510-9E1BDFCF-B6FF-4B95-9255-4FB3C55A6C62Q37409722-6A3D62B2-5DC4-4DA8-B1FD-F18ECFA7692FQ37419826-F7AE74BB-F7A5-41BF-8CFD-FB0FA068DAD6Q37423671-1ACB19B0-5271-4561-93E5-A6F450C9B865Q37858452-F25624AB-1282-4C2D-BF79-9E42FF80DDEFQ37973166-804A679C-FC51-4E97-9F6B-E18705F69BD8Q38372662-FD938435-359D-4D6F-83FA-EBAFC70A1F0FQ38475163-428A615F-D92C-4BBE-A8D7-38C69E060F01
P2860
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Survival with the acquired imm ...... h 5833 cases in New York City.
@en
Survival with the acquired imm ...... h 5833 cases in New York City.
@nl
type
label
Survival with the acquired imm ...... h 5833 cases in New York City.
@en
Survival with the acquired imm ...... h 5833 cases in New York City.
@nl
prefLabel
Survival with the acquired imm ...... h 5833 cases in New York City.
@en
Survival with the acquired imm ...... h 5833 cases in New York City.
@nl
P2093
P1476
Survival with the acquired imm ...... h 5833 cases in New York City.
@en
P2093
Rothenberg R
Stoneburner R
P304
P356
10.1056/NEJM198711193172101
P407
P577
1987-11-01T00:00:00Z